260
Views
2
CrossRef citations to date
0
Altmetric
Articles

Prevalence and factors associated with fast resting heart rate in hypertensive and normotensive patients

, , , , , , & show all
Pages 8-15 | Received 12 Sep 2018, Accepted 03 Dec 2018, Published online: 19 Dec 2018

References

  • Zhong C, Zhong X, Xu T, Peng H, Li H, Zhang M, Wang A, Xu T, Sun Y, Zhang Y. Combined effects of hypertension and heart rate on the risk of stroke and coronary heart disease: a population-based prospective cohort study among Inner Mongolians in China. Hypertens Res. 2015;38:883–88. doi:10.1038/hr.2015.90.
  • Sandset EC, Berge E, Kjeldsen SE, Julius S, Holzhauer B, Krarup L-H, Hua TA. Heart rate as a predictor of stroke in high-risk, hypertensive patients with previous stroke or transient ischemic attack. J Stroke Cerebrovasc Dis. 2014;23:2814–18. doi:10.1016/j.jstrokecerebrovasdis.2014.07.009.
  • Ryu M, Bayasgalan G, Kimm H, Nam CM, Ohrr H. Association of resting heart rate and hypertension stages on all-cause and cardiovascular mortality among elderly Koreans: the Kangwha cohort study. J Geriatr Cardiol. 2016;13:573–79. doi:10.11909/j.issn.1671-5411.2016.07.003.
  • Kannel WB, Kannel C, Paffenbarger RS, Cupples LA. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J. 1987;113:1489–94.
  • Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Böhm M. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol. 2014;103:149–59. doi:10.1007/s00392-013-0644-4.
  • Palatini P, Rosei EA, Casiglia E, Chalmers J, Ferrari R, Grassi G, Inoue T, Jelakovic B, Jensen MT, Julius S, et al. Management of the hypertensive patient with elevated heart rate: statement of the second consensus conference endorsed by the European Society of Hypertension. J Hypertens. 2016;34:813–21. doi:10.1097/HJH.0000000000000865.
  • Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545–53. doi:10.1016/S0140-6736(05)67573-3.
  • Sun NL, Huo Y, Huang J. The current status of heart rate in Chinese hypertensive patients. Chin J Hypertens. 2015;934–39. doi:10.16439/j.cnki.1673-7245.2015.10.013.
  • Li HY, Yang XH, Zuo HJ, Yao C-H. Analysis of outpatient hypertension treatment among different grade hospitals in Beijing. Zhonghua Xin Xue Guan Bing Za Zhi. 2005;33:174–77. doi:10.3760/j:issn:0253-3758.2005.02.017.
  • Zhang W, Sun K, Yang Y, Zhang H, Hu FB, Hui R. Plasma uric acid and hypertension in a Chinese community: prospective study and meta-analysis. Clin Chem. 2009;55:2026–34. doi:10.1373/clinchem.2009.124891.
  • Fan XH, Han Y, Sun K, Wang Y, Xin Y, Bai Y, Li W, Yang T, Song X, Wang H, et al. Sex differences in blood pressure response to antihypertensive therapy in Chinese patients with hypertension. Ann Pharmacother. 2008;42:1772–81. doi:10.1345/aph.1L036.
  • He YJ, Tao QS, Li XT. Influences of gender and age on correlation of BMI and BF percentage in adult. Chin J Publish Health. 2009;04:441–43. doi:10.3321/j.issn:1001-0580.2009.04.021.
  • Drenjancevic I, Grizelj I, Harsanji-Drenjancevic I, Cavka A, Selthofer-Relatic K. The interplay between sympathetic overactivity, hypertension and heart rate variability (review, invited). Acta Physiol Hung. 2014;101:129–42. doi:10.1556/APhysiol.101.2014.2.1.
  • Aladin AI, Al Rifai M, Rasool SH, Keteyian SJ, Brawner CA, Michos ED, Blaha MJ, Al-Mallah MH, McEvoy JW. The association of resting heart rate and incident hypertension: the Henry Ford hospital exercise testing (FIT) project. Am J Hypertens. 2016;29:251–57. doi:10.1093/ajh/hpv095.
  • Ji C, Zheng X, Chen S, Dong Y, Yang G, Gao X, Tao J, Wu S. Impact of resting heart rate on the progression to hypertension in prehypertension patients. Zhonghua Xin Xue Guan Bing Za Zhi. 2014;42:860–65. doi:10.3760/cma.j.issn.0253–3758.2014.10.014.
  • Xu T, Bu X, Li H, Zhang M, Wang A, Tong W, Xu T, Sun Y, Zhang Y. Smoking, heart rate, and ischemic stroke: a population-based prospective cohort study among inner Mongolians in China. Stroke. 2013;44:2457–61. doi:10.1161/STROKEAHA.111.000648.
  • Murakami R, Matsuda T, Koitabashi K. Effect on cardiovascular system and autonomic nervous system in healthy adults with different body types while performing movements simulating washing of the lower limbs for cardiac rehabilitation. Jpn J Nurs Sci. 2012;9:149–59. doi:10.1111/j.1742-7924.2011.00195.x.
  • Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–78. doi:10.1056/NEJMoa055643.
  • Niedziela J, Hudzik B, Niedziela N, Gąsior M, Gierlotka M, Wasilewski J, Myrda K, Lekston A, Poloński L, Rozentryt P. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29:801–12. doi:10.1007/s10654-014-9961-9.
  • Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez-Jimenez F, Arbab-Zadeh A, Mukherjee D, Lazar JM. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;115:1428–34. doi:10.1016/j.amjcard.2015.02.024.
  • Javed A, Jumean M, Murad MH, Okorodudu D, Kumar S, Somers VK, Sochor O, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity in children and adolescents: a systematic review and meta-analysis. Pediatr Obes. 2015;10:234–44. doi:10.1111/ijpo.242.
  • Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63:1345–54. doi:10.1016/j.jacc.2014.01.022.
  • Morcet JF, Safar M, Thomas F, Guize L, Benetos A. Associations between heart rate and other risk factors in a large French population. J Hypertens. 1999;17:1671–76.
  • Brundisini F, Giacomini M, Dejean D, Vanstone M, Winsor S, Smith A. Chronic disease patients’ experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013;13:1–33.
  • Palatini P. Heart rate and the cardiometabolic risk. Curr Hypertens Rep. 2013;15:253–59. doi:10.1007/s11906-013-0342-7.
  • Yang HI, Kim HC, Jeon JY. The association of resting heart rate with diabetes, hypertension, and metabolic syndrome in the Korean adult population: the fifth Korea national health and nutrition examination survey. Clin Chim Acta. 2016;455:195–200. doi:10.1016/j.cca.2016.01.006.
  • Li YQ, Sun CQ, Li LL, Wang CJ, Guo Y-R, You A-G, Xi Y-L, Wang C-J. Resting heart rate as a marker for identifying the risk of undiagnosed type 2 diabetes mellitus: a cross-sectional survey. BMC Public Health. 2014;14:1052–58. doi:10.1186/1471-2458-14-1052.
  • Hillis GS, Woodward M, Rodgers A, Chow CK, Li Q, Zoungas S, Patel A, Webster R, Batty GD, Ninomiya T, et al. Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia. 2012;55:1283–90. doi:10.1007/s00125-012-2471-y.
  • Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CVS, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14–26. doi:10.1111/jch.12237.
  • Fonseca V, Sharma PP, Shah M, Deedwania P. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension. Curr Med Res Opin. 2011;27:799–807. doi:10.1185/03007995.2011.555477.
  • Vanhoutte PM, Gao Y. Beta blockers, nitric oxide, and cardiovascular disease. Curr Opin Pharmacol. 2013;13:265–73. doi:10.1016/j.coph.2012.12.002.
  • Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating beta-blockers. J Clin Hypertens (Greenwich). 2011;13:52–59. doi:10.1111/j.1751-7176.2010.00386.x.
  • O’Neal WT, Qureshi WT, Judd SE, Meschia JF, Howard VJ, Howard G, Soliman EZ. Heart rate and ischemic stroke: the reasons for geographic and racial differences in stroke (REGARDS) study. Int J Stroke. 2015;10:1229–35. doi:10.1111/ijs.12620.
  • Custodis F, Baumhakel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2008;117:2377–87. doi:10.1161/CIRCULATIONAHA.107.746537.
  • Bohm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PMW, Yusuf S, Diener H-C. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J. 2012;33:2804–12. doi:10.1093/eurheartj/ehs250.
  • Dorrance AM, Fink G. Effects of stroke on the autonomic nervous system. Compr Physiol. 2015;5:1241–63. doi:10.1002/cphy.c140016.
  • Zhang D, Wang W, Li F. Association between resting heart rate and coronary artery disease, stroke, sudden death and noncardiovascular diseases: a meta-analysis. CMAJ. 2016;188:E384–392. doi:10.1503/cmaj.160050.
  • National Collaborating Centre for Chronic Conditions(UK). Hypertension: management in adults in primary care: pharmacological update. London: Royal College of Physicians (UK); 2006.
  • Palatini P, Rosei EA, Casiglia E, Chalmers J, Ferrari R, Grassi G, Inoue T, Jelakovic B, Jensen MT, Julius S, Kjeldsen SE, Mancia G, Parati G, Pauletto P, Stella A and Zanchetti A. Management of the hypertensive patient with elevated heart rate: statement of the Second Consensus Conference endorsed by the European Society of Hypertension. J Hypertens. 2016;34:813–21. doi: 10.1097/HJH.0000000000000865.39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.